Skip to Content
Cancer Therapy Evaluation Program (CTEP)
Contact NExT
Show menu
Search this site
Last Updated: 01/06/14

Jack Welch, MD, PhD

Jack Welch, MD, PhD

Head — GI, Thoracic, and Neuroendocrine Cancer Therapeutics

Jack Welch, MD, PhD, is Head of Gastrointestinal and Neuroendocrine Cancers Therapeutics in the Clinical Investigations Branch of the Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis, at the NCI. Dr. Welch is the assigned scientific liaison to the Eastern Clinical Oncology Group.

Dr. Welch came to CTEP from the European Organisation for the Research and Treatment of Cancer (EORTC), where he was a senior clinical research physician, with a portfolio including gastrointestinal and lung cancers, as well as cutaneous lymphomas.

Dr. Welch received his B.S. in Biology from Georgetown University, his M.D. degree from the State University of New York at Buffalo, and his Ph.D. in Pharmacology from Roswell Park Cancer Institute. He completed a pediatric residency at Georgetown University, and subsequent fellowship in Pediatric Hematology-Oncology at the Children’s Hospital of Philadelphia.

Contact Information:
National Cancer Institute
9609 Medical Center Dr., MSC 9739
For USPS: Bethesda, MD 20892-9739
For Express and Courier: Rockville, MD 20850
Phone: 240-276-6560
Fax: 240-276-7892

About the Branch Chief

Meg Mooney, MD Meg Mooney, MD, MBA, became the Acting Associate Director of CTEP in December 2018, with oversight and coordination responsibilities for the programmatic, financial, and administrative functions for the entire CTEP program, which covers a broad, multidisciplinary, clinical research effort to coordinate nationwide phase 1-3 clinical trials programs testing new treatment approaches for cancer. She is also the Chief of the Clinical Investigations Branch. More…